-
Kyle Bass: We're In 6th Inning Of Emerging Market Selloff, 'Still Have Three Tough Innings To Go'
Friday, January 22, 2016 - 5:27pm | 223In new yet-to-be released commentary on Wall Street Week, Kyle Bass of Hayman Capital sheds light on his view into the deteriorating emerging market situation. Bass said he thinks emerging markets are "probably in the mid-fifth inning...maybe entering the sixth" of their current selloff...
-
Kyle Bass Sees A 10-20% Decline In The U.S. Market
Sunday, January 10, 2016 - 8:37pm | 203Kyle Bass of Hayman Capital Management spoke on CNBC's Fast Money Halftime Report about current headwinds for the market. He thinks that the real issue is the size of the banking system in China. Bass explained that European countries ended up falling like dominoes during the European...
-
Kyle Bass Explains The 'Patent Trolls' Situation In The Pharma Industry
Saturday, January 2, 2016 - 9:38pm | 465Benzinga receives exclusive access to previews of the upcoming weeks’ Wall Street Week. This Sunday’s episode will feature Kyle Bass, founder and principal of Hayman Capital Management. Bass, who manages $1.7 billion in assets, went into several topics including his ongoing...
-
Kyle Bass Recommends The Energy Sector; The Time Is Now
Saturday, January 2, 2016 - 9:05pm | 443The people at Wall Street Week were kind enough to share a preview of this Sunday’s show with Benzinga. The upcoming episode will feature Kyle Bass, founder and principal of Hayman Capital Management. The investor, who manages more than $16 billion in assets, went into several topics...
-
Kyle Bass On U.S. Oil Production: Going From Glut To Deficit, 'The World's Not Ready'
Saturday, January 2, 2016 - 9:05pm | 456Benzinga received a sneak peek of this Sunday’s Wall Street Week. The upcoming episode will feature Kyle Bass, founder and principal of Hayman Capital Management, who manages $1.7 billion in assets. The expert went into several topics including his ongoing pharmaceutical patent battles and...
-
Celgene Will 'Vigorously' Defend IP Amid Report Kyle Bass Patent Challenge Could Prove Successful
Tuesday, October 27, 2015 - 2:52pm | 242Shares of Celgene Corporation(NASDAQ: CELG) on Tuesday plunged to a mid-day low of $121.41. The move came in response to a Bloomberg report the U.S. Patent & Trademark Organization may soon be reviewing a patent challenge brought on by Kyle Bass's Coalition for Affordable Drugs related to...
-
Jim Chanos, Kyle Bass Rip Oil And Pharma At SALT 2015
Thursday, May 7, 2015 - 5:39pm | 501It's midway through Day 3 of SALT 2015, presented by SkyBridge Capital, and a handful of publicly-traded names have been discussed by the biggest hedge fund managers on the planet. Jim Chanos Short Royal Dutch Shell, Chevron Chanos began his presentation with a slideshow covering his...
-
SALT 2015: Top Investment Ideas From Bass, Burbank, Chanos & Cooperman
Thursday, May 7, 2015 - 5:22pm | 744Some of the top investment managers in the United States presented some of their best investment themes and ideas at SALT Conference 2015 on Thursday. The panel was moderated by Omeed Malik and panelists consisted of Kyle Bass, John Burbank, Jim Chanos, Leon Cooperman and Michael Karsh. Leon...
-
Kyle Bass Challenges Biogen Fumaderm Patent
Wednesday, April 22, 2015 - 12:58pm | 164A patent held by Biogen Inc (NASDAQ: BIIB) on its Fumaderm psoriasis treatment got challenged Tuesday by hedge fund manager and short seller Kyle Bass. Fumaderm, acquired by Biogen in 2006, accounted for $62 million of Biogen's $8.2 billion in 2014 product revenue. Biogen changed hands...
-
Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent
Monday, April 20, 2015 - 4:09pm | 250Pharmacyclics, Inc. (NASDAQ: PCYC) fell victim Monday to the latest patent challenge by hedge fund manager and short seller Kyle Bass. AbbVie Inc (NYSE: ABBV) agreed last month to acquire Pharmacyclics for $21 billion. Dallas-based Hayman Capital Management L.P., managed by Bass, challenged...
-
General Motors Under The Grip Of Activists
Tuesday, February 10, 2015 - 5:10pm | 426It seems the recent upbeat results and raise in dividends by General Motors Company (NYSE: GM) were not enough to satisfy some shareholders. It was revealed on Tuesday, February 10, that four hedge funds have combined their powers to fight for a seat in the company’s board and push...
-
Kyle Bass On CNBC: General Motors Could Double Its Dividend
Friday, January 23, 2015 - 11:06am | 153Hayman Capital's Kyle Bass spoke about General Motors Company (NYSE: GM) on CNBC Friday. Bass claimed that the automaker has “too much capital on its balance sheet.” “With $27 billion in cash and doing $15 billion a year in EBITDA and...$5 or $6 billion in free cash flow,...
-
Kyle Bass Exits Facebook, Ups General Motors Holdings
Friday, November 14, 2014 - 12:28pm | 456Kyle Bass' Hayman Capital Management LP added to his position in General Motors Company (NYSE: GM) and exited Facebook Inc (NASDAQ: FB) in the third quarter. Bass, who made a fortune betting against mortgage-backed bonds in the 2008 crash, said in a quarterly regulatory filing that his...
-
Dan Loeb, Kyle Bass And Other Star Investors Love This Startup
Friday, October 31, 2014 - 12:27pm | 516Harvest, a financial discovery and communication platform, wants to take over Wall Street -- one investor at a time. The startup has already succeeded in attracting a number of well-known users, including Dan Loeb, Kyle Bass, Steve Tananbaum, Jody Lanasa and Sahm Adrangi. Numerous firms (...
-
GM Shares Resisting Constant Recall News
Tuesday, March 18, 2014 - 1:36pm | 648Despite the announcement of multiple recalls, General Motors (NYSE: GM) shares have been holding up fairly well over the last few trading sessions. In fact, after Monday's revelation of three new recalls, the issue immediately retreated $0.84 from $34.55 to $33.71, before rallying to close higher...